Senior TA Strategy Lead - Specialty |
Tokyo |
日本 |
|
|
市场营销 |
Avr 25, 2024 |
Oncology Specialist - RLT- Portland- Remote |
Field Sales (USA) |
美国 |
|
|
销售 |
Avr 29, 2024 |
Expert Medical Information Manager |
INSURGENTES |
墨西哥 |
|
CTS |
Research & Development |
Avr 29, 2024 |
Executive Director, US Patient Advocacy |
East Hanover |
美国 |
|
CTS |
Communications & Public Affairs |
Mai 02, 2024 |
Oncology Area Business Leader - RLT- Detroit- Remote |
Remote |
美国 |
|
Pharmaceuticals |
销售 |
Avr 19, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
中国 |
|
Pharmaceuticals |
销售 |
Mai 09, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
中国 |
|
Pharmaceuticals |
销售 |
Mai 09, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
中国 |
|
Pharmaceuticals |
销售 |
Mai 09, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
中国 |
|
Pharmaceuticals |
销售 |
Mai 09, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
中国 |
|
Pharmaceuticals |
销售 |
Mai 09, 2024 |
Executive Director, US Corporate Communication |
East Hanover |
美国 |
|
CTS |
Communications & Public Affairs |
Mai 02, 2024 |
Executive Director, Public Affairs LaCan Region |
East Hanover |
美国 |
|
Corporate |
Communications & Public Affairs |
Mai 09, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
中国 |
|
Pharmaceuticals |
销售 |
Mai 09, 2024 |
AD, Access & Reimbursement- Nashville |
Field Non-Sales (USA) |
美国 |
|
Pharmaceuticals |
Market Access |
Mai 08, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
中国 |
|
Pharmaceuticals |
销售 |
Mai 09, 2024 |
Clinical Project Manager |
Prague |
捷克共和国 |
|
CTS |
Research & Development |
Mai 09, 2024 |
Microsoft 365 Solution Architect |
Prague |
捷克共和国 |
|
|
|
Mai 16, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
中国 |
|
Pharmaceuticals |
销售 |
Mai 09, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
中国 |
|
Pharmaceuticals |
销售 |
Mai 09, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
中国 |
|
Pharmaceuticals |
销售 |
Mai 09, 2024 |
(高级)医药代表 /(资深)产品专员 |
Kunming (Yunnan Province) |
中国 |
|
Pharmaceuticals |
销售 |
Avr 16, 2024 |
(高级)医药代表 /(资深)产品专员 |
Chongqing (Chongqing Province) |
中国 |
|
Pharmaceuticals |
销售 |
Avr 22, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shanghai (Shanghai) |
中国 |
|
Pharmaceuticals |
销售 |
Mai 09, 2024 |
SMR |
Beijing (Beijing) |
中国 |
|
|
销售 |
Mai 16, 2024 |
Cardiologist Physician Scientist, Translational Medicine |
Cambridge, MA |
美国 |
Biomedical Research |
Translational Medicine |
Research & Development |
Mar 07, 2024 |
Clinical Program Leader |
Cambridge, MA |
美国 |
Biomedical Research |
TCO NIBR |
Research & Development |
Nov 21, 2023 |
Clinical Program Leader |
Cambridge, MA |
美国 |
Biomedical Research |
TCO NIBR |
Research & Development |
Nov 21, 2023 |
Applied Computational Biologist, Renal I |
Cambridge, MA |
美国 |
Biomedical Research |
DAX - NIBR |
Data Science |
Mar 08, 2024 |
Discovery Postdoctoral Fellow, Covalent Drug Discovery |
Cambridge, MA |
美国 |
Biomedical Research |
DSc |
Research & Development |
Mar 07, 2024 |
Japan Clinical Trial Lead |
Tokyo |
日本 |
Biomedical Research |
TCO NIBR |
Research & Development |
Mar 08, 2024 |
Medical Director, Clinical Pharmacology |
East Hanover, NJ |
美国 |
Biomedical Research |
Translational Medicine |
Research & Development |
Mar 05, 2024 |
Research Informatics Product Growth Manager x3 (Switzerland or US) |
Basel |
瑞士 |
Biomedical Research |
DSc |
Research & Development |
Avr 11, 2024 |
Associate Director Product Growth Manager x3 (US or Switzerland) |
Cambridge, MA |
美国 |
Biomedical Research |
DSc |
Research & Development |
Mar 01, 2024 |
Associate Director, PK Sciences |
Cambridge, MA |
美国 |
Biomedical Research |
Translational Medicine |
Research & Development |
Mar 21, 2024 |
Senior Principal Scientist, Computational Medicinal Chemistry |
Cambridge, MA |
美国 |
Biomedical Research |
Global Discovery Chemistry |
Data Science |
Jan 23, 2024 |
Research Informatics, Associate Director Business Relationship Mgmt |
Cambridge, MA |
美国 |
Biomedical Research |
DSc |
Research & Development |
Avr 19, 2024 |
Medical Director / Rheumatology, Autoimmune Translational Medicine |
Basel |
瑞士 |
Biomedical Research |
Translational Medicine |
Research & Development |
Nov 01, 2023 |
Medical Director - Dermatology Translational Medicine |
Basel |
瑞士 |
Biomedical Research |
Translational Medicine |
Research & Development |
Fév 27, 2024 |
Senior Scientist PKS (In vivo preclinical PK/ADME) |
Basel |
瑞士 |
Biomedical Research |
Translational Medicine |
Research & Development |
Fév 07, 2024 |
CVM Therapeutic Area Biomarker Lead |
Cambridge, MA |
美国 |
Biomedical Research |
Translational Medicine |
Research & Development |
Fév 23, 2024 |
Medical Director, Translational Medicine (Neuroscience) |
Cambridge, MA |
美国 |
Biomedical Research |
Translational Medicine |
Research & Development |
Fév 27, 2024 |
Senior Scientist - Radioligand Therapy in-vivo Oncology (80-100%*) |
Basel |
瑞士 |
Biomedical Research |
Oncology NIBR |
Research & Development |
Mar 21, 2024 |
Clinical Data Specialist |
Hyderabad, AP |
印度 |
Biomedical Research |
Translational Medicine |
Research & Development |
Avr 01, 2024 |
Principal Scientist, Translational Modeling & Simulation |
Cambridge, MA |
美国 |
Biomedical Research |
Translational Medicine |
Research & Development |
Mar 22, 2024 |
Sr Principal Scientist/ Assoc Director, Translational Modeling (M&S) |
Cambridge, MA |
美国 |
Biomedical Research |
Translational Medicine |
Research & Development |
Mar 22, 2024 |
Medical Director, Translational Medicine Immunology |
East Hanover, NJ |
美国 |
Biomedical Research |
Translational Medicine |
Research & Development |
Mar 25, 2024 |
Medical Director, Neuroscience Translational Medicine |
Cambridge, MA |
美国 |
Biomedical Research |
Translational Medicine |
Research & Development |
Mar 25, 2024 |
Senior Scientist, Clinical Genetics and Genomics |
Cambridge, MA |
美国 |
Biomedical Research |
Translational Medicine |
Research & Development |
Mar 19, 2024 |
Associate Submission Manager |
Hyderabad, AP |
印度 |
Biomedical Research |
Translational Medicine |
Research & Development |
Mar 20, 2024 |
Associate Clinical Trial Leader |
Hyderabad, AP |
印度 |
Biomedical Research |
TCO NIBR |
Research & Development |
Mar 18, 2024 |